» Articles » PMID: 8352162

The Radiologic Prediction of Alzheimer Disease: the Atrophic Hippocampal Formation

Overview
Specialty Neurology
Date 1993 Jul 1
PMID 8352162
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To test the hypothesis that atrophy of the hippocampal formation in nondemented elderly individuals would predict subsequent Alzheimer disease.

Method: We studied 86 subjects at two time points, 4 years apart. At baseline all study subjects were nondemented and included 54 control subjects and 32 persons who had memory complaints and minimal cognitive impairments. All subjects received a CT scan using a protocol designed to image the perihippocampal cerebrospinal fluid (HCSF) accumulating in the fissures along the axis of the hippocampal formation. Blind to the clinical evaluations, we subjectively assessed the presence of HCSF at the baseline. Retrospectively, we examined the predicted association between baseline HCSF and clinical decline as determined across the two evaluations.

Results: At follow-up 25 of the 86 subjects had deteriorated and received the diagnosis of Alzheimer disease. Of the declining subjects, 23 came from the minimally impaired group, and 2 came from the control group. In the minimally impaired group the baseline HCSF measure had a sensitivity of 91% and a specificity of 89% as a predictor of decline. Both control subjects who deteriorated were also correctly identified at baseline. One of these two subjects died, and an autopsy confirmed the presence of Alzheimer disease. M(r) validation studies demonstrated that HCSF is quantitatively related to dilatation of the transverse fissure of Bichat and the choroidal and hippocampal fissures.

Conclusion: Our findings strongly suggest that among persons with mild memory impairments, dilatation of the perihippocampal fissures is a useful radiologic marker for identifying the early features of Alzheimer disease.

Citing Articles

Causal relationship between hippocampal subfield volume and alzheimer's disease: a mendelian randomization study.

Wan S, Wang S, Zhang X, Li H, Sun M, Chen G Neurol Sci. 2025; .

PMID: 39775366 DOI: 10.1007/s10072-024-07976-w.


Linear brain measurement: a new screening method for cognitive impairment in elderly patients with cerebral small vessel disease.

Wang J, Lu J, He M, Song Z, Dong L, Tang H Front Neurol. 2024; 15:1297076.

PMID: 38318441 PMC: 10840835. DOI: 10.3389/fneur.2024.1297076.


Aging-related volume changes in the brain and cerebrospinal fluid using artificial intelligence-automated segmentation.

Yamada S, Otani T, Ii S, Kawano H, Nozaki K, Wada S Eur Radiol. 2023; 33(10):7099-7112.

PMID: 37060450 PMC: 10511609. DOI: 10.1007/s00330-023-09632-x.


Generalizable deep learning model for early Alzheimer's disease detection from structural MRIs.

Liu S, Masurkar A, Rusinek H, Chen J, Zhang B, Zhu W Sci Rep. 2022; 12(1):17106.

PMID: 36253382 PMC: 9576679. DOI: 10.1038/s41598-022-20674-x.


Distributions of Aβ42 and Aβ42/40 in the Cerebrospinal Fluid in View of the Probability Theory.

Lewczuk P, Wiltfang J, Kornhuber J, Verhasselt A Diagnostics (Basel). 2021; 11(12).

PMID: 34943609 PMC: 8700661. DOI: 10.3390/diagnostics11122372.